Impact of Prophylactic Steroids on CAR T-cell Related Toxicity for Relapsed and Refractory Non-Hodgkin Lymphoma. (PubMed, Transplant Cell Ther) - Oct 13, 2026 - "Prophylactic corticosteroids did not impact CRS, ICANS, response rates, or survival. Although CRS onset may be modestly delayed, these findings do not support routine steroid prophylaxis in CAR-T-treated NHL patients."
Journal • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
|
|
Aharon G Freud; Alma Habib; Audrey Sigmund; Beth Christian; David A Bond; Gabriela Sanchez-Pettito; Hannah Choe; Jacob Butman; Jiasheng Wang; John C Reneau; Jonathan Brammer; Jordan Krull; Kami Maddocks; Lapo Alinari; Marcos de Lima; Mark P Rubinstein; Nathan Denlinger; No-Joon Song; Polina Shindiapina; Rina Li Welkie; Robert A Baiocchi; Sarah Wall; Sumithira Vasu; Timothy J Voorhees; Walter Hanel; Wing Chan; Yazeed Sawalha; Youssef Youssef
|